Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients
- 1 September 2019
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 2 (5) , 483-489
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma and Amgen
This publication has 23 references indexed in Scilit:
- Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible PatientsEuropean Urology Oncology, 2018
- Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in SwedenJAMA Oncology, 2017
- How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United StatesJournal of Urology, 2016
- Active surveillance for prostate cancer: current evidence and contemporary state of practiceNature Reviews Urology, 2016
- How Often is Biopsy Necessary in Patients with Prostate Cancer on Active Surveillance?Journal of Urology, 2016
- Current use of active surveillance for localized prostate cancer: A nationwide survey in JapanInternational Journal of Urology, 2015
- The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the V ictorian Prostate Cancer RegistryBJU International, 2015
- Active surveillance for low-risk prostate cancer: diversity of practice across EuropeIrish Journal of Medical Science (1971 -), 2014
- Population Based Study of Use and Determinants of Active Surveillance and Watchful Waiting for Low and Intermediate Risk Prostate CancerJournal of Urology, 2013
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS StudyEuropean Urology, 2013